Vinylogous amino acids (insertion of ꢀCHdCHꢀ be-
tween CRH and CO, R,β-unsaturated-γ-amino acids) have
been frequently found in many peptide natural products.11
The structures of R,β-unsaturated γ-amino acids and their
oligomers have little explored. Nevertheless, Schreiber and
colleagues12 and others13 reported the β-sheet, β-turn, and
unusual helical type of structures for the peptides contain-
ing vinylogous amino acids. Recently, we reported the
utility of E-vinylogous amino acids in the construction of a
stable and functionalizable hybrid β-hairpin.14 In conti-
nuation of our studies in the design of hybrid peptides
containing E-vinylogous amino acids, we designed the
peptides D1 and D2 to understand the behavior of vinylo-
gous amino acids in the presence of conformationally
constrained, helixfavoringAib residues15 and to transform
into their saturated γ-peptide analogues (Scheme 1). Further,
this approach also provides an unprecedented opportunity
to analyze and understand the conformational preferences
of both R,β-unsaturated and saturated γ4-amino acids in
oligopeptides. The E-vinylogous amino acid dgF [(S,E)-4-
amino-5-phenylpent-2-enoic acid] was synthesized using
the Wittig reaction starting from N-Boc-(S)-phenylalanal.16
Peptides D1 and D2 were synthesized in the solution-phase
method using Boc chemistry.
Scheme 1. Direct Transformation of R/Vinylogous Hybrid
Peptides (D) to R/γ4-Hybrid Peptides (G)a
a The sequences of R/vinylogous hybrid peptides (D1 and D2) and
R/γ4-hybrid peptides (G1 and G2) are shown.
We began our analysis with D1; the 1H NMR shows the
wide dispersion of NH and vinylic protons. Surprisingly,
the 2D NMR (ROESY) analysis reveals that no character-
istic intramolecular NOEs corresponding to either the
helix, sheet or reverse turn conformations (see the Sup-
porting Information), indicating no secondary structure in
the hybrid peptide. Similarly, the solution structure analysis
of D2 suggests no regular secondary structures. Further,
we were able to get single crystals of D1 from the slow
evaporation of methanol/toluene solution, and its X-ray
structure is shown in Figure 1. Interestingly, D1 adopted
an unusual planar structure in crystalline state and as
anticipated did not show any protein secondary structural
properties. No intramolecular H-bonding is observed in
the crystal structure. Examination of the torsional angles
of helix favoring Aib residues reveal that both residues
adopted opposite right and left handed helical conforma-
tions with the φ and ψ values ꢀ51, ꢀ48, and 64 and 52,
respectively. The local conformations of the vinylogous
residues were determined by introducing additional torsional
variables θ1 (NꢀCγꢀCβdCR) and θ2 (CγꢀCβdCRꢀC) as
shown in Figure 1. The vinylogous residue dgF2 adopted a
fully extended conformation by having the torsional angles
φ=ꢀ139, θ1 =121,θ2 = 178, and ψ=ꢀ161ꢀ. Interestingly,
another vinylogous residue, dgF4 adopted NꢀCγꢀCβdCR
Figure 1. X-ray structures of hybrid R-vinylogous peptide (D1)
and R/γ4-hybrid peptide (G1). Local torsional variables of γ-
residues are shown at the top.
oligomers of unsubstituted γ-amino acids, R,β-unsatu-
rated γ-amino acids and 1:1 heterooligomers of R/γ-amino
acids using ab initio theoretical calculations.10 Here we
report the unusual planar structures of the R/vinylogous
hybrid peptides Boc-Aib-dgF-Aib-dgF-OEt (D1, dgF =
R,β- dehydro γ4-phenylalanine) and Boc-Ala-dgF-Aib-
dgF- OEt (D2) and their direct transformation to ordered
R/γ4-hybrid peptide 12-helices, Boc-Aib-γ4Phe-Aib-γ4Phe-
OEt (G1) and Boc-Ala-γ4Phe-Aib-γ4Phe-OEt (G2), respec-
tively, using catalytic hydrogenation.
(12) Hagihara, M.; Anthony, N. J.; Stout, T. J.; Clardy, J.; Schreiber,
S. L. J. Am. Chem. Soc. 1992, 114, 6568–6570.
(13) (a) Grison, C.; Coutrot, P.; Geneve, S.; Didierjean, C.; Marraud,
M. J. Org. Chem. 2005, 70, 10753–10764. (b) Chakraborty, T. K.;
Ghosh, A.; Kumar, S. K.; Kunwar, A. C. J. Org. Chem. 2003, 68,
6459–6462.
(10) (a) Baldauf, C.; Gunther, R.; Hofmann, H.-J. Helv. Chim. Acta
2003, 86, 2573–2588. (b) Baldauf, C.; Gunther, R.; Hofmann, H.-J.
J. Org. Chem. 2005, 70, 5351–5361. (c) Baldauf, C.; Gunther, R.;
Hofmann, H.-J. J. Org. Chem. 2006, 71, 1200–1208.
(14) Bandyopadhyay, A.; Mali, S. M.; Lunawat, P.; Raja, K. M. P.;
Gopi, H. N. Org. Lett. 2011, 13, 4482–4485.
(15) (a) Toniolo, C.; Benedetti, E. Trends Biochem. Sci. 1991, 16, 350–
353. (b) Karle, I. L.; Balaram, P. Biochemistry 1990, 29, 6747–6756.
(16) Mali, S. M.; Bandyopadhyay, A.; Jadhav, S. V.; Ganesh Kumar,
M.; Gopi, H. N. Org. Biomol. Chem. 2011, 9, 6566–6574.
(11) (a) Linington, R. G.; Clark, B. R.; Trimble, E. E.; Almanza, A.;
Uren, L. D.; Kyle, D. E.; Gerwick, W. H. J. Nat. Prod. 2009, 72, 14–17.
(b) Coleman, J. E.; de Silva, E. D.; Kong, F.; Andersen, R. J.; Allen,
T. M. Tetrahedron 1995, 51, 10653–10662.
Org. Lett., Vol. 14, No. 11, 2012
2771